Skip to main content
. 2015 Jun 22;10(6):e0131293. doi: 10.1371/journal.pone.0131293

Table 1. General characteristics of the study population (median with 25th/75th percentile).

Subjects without increased IMT Subjects with increased IMT P
(n = 1489) (n = 510)
Age (years) 61 (54; 69) 62 (54; 70) 0.11
% male 51.8 52.0 0.94
Smoking (%) Ex-smoker 40.5 39.8 0.21
Smoker 17.5 20.9
Nonsmoker 42.0 39.3
% Physically active 35.9 30.4 0.02
WHR 0.89 (0.82; 0.95) 0.90 (0.83; 0.95) 0.15
eGFR (mL/min/1.73m2) 74 (66; 83) 74 (65; 82) 0.30
Hypertensive (%) 65.4 78.4 < 0.001
Diabetes mellitus (%) 15.1 24.2 < 0.001
cIMT (mm) 0.83 (0.76; 0.93) 1.12 (0.99; 1.27) < 0.001
ADMA (μmol/L) 0.69 (0.61; 0.79) 0.70 (0.62; 0.79) 0.17
SDMA (μmol/L) 0.47 (0.40; 0.55) 0.48 (0.41; 0.58) 0.05
ARG (μmol/L) 150.1 (119.4; 184.6) 152.2 (122.3; 188.4) 0.34
DMA (μmol/L) 1.18 (1.04; 1.31) 1.19 (1.06; 1.36) 0.07
ARG/ADMA 218.5 (168.9; 266.5) 211.9 (170.9; 270.3) 0.81
Plaque (%) 67.12 83.07 < 0.001

Data are represented as median (interquartile range), or n (%). WHR indicates waist-to-hip ratio; eGFR, estimated-glomerular-filtration-rate; cIMT, carotid intima-media-thickness; ADMA, asymmetrical dimethylarginine; SDMA, symmetrical dimethylarginine; ARG, ˪-Arginine; DMA, dimethylarginine; ARG/ADMA, Arginine-asymmetrical dimethylarginine ratio.